Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Milestone Pharmaceuticals (Nasdaq: MIST) will present at the 25th Annual Needham Virtual Healthcare Conference April 13–16, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Milestone Pharmaceuticals (Nasdaq: MIST) will present at the 25th Annual Needham Virtual Healthcare Conference April 13–16, 2026. Management's webcast is scheduled for April 13, 2026 at 3:45 PM EDT.
According to the company, the presentation webcast will be available April 13 with a replay accessible for approximately 90 days on Milestone's News & Events page. Investors seeking meetings should contact their Needham representative.
Details
News Market Reaction – MIST
On Apr 7, the day this news came out, MIST closed 5.92% above the previous close.
Data tracked by StockTitan Argus for the Apr 7 session.
Key Figures
- Conference dates
- April 13 - 16, 2026
- 25th Annual Needham Virtual Healthcare Conference
- Presentation time
- 3:45 PM EDT
- Webcast available April 13
- Webcast replay length
- approximately 90 days
- Replay on Milestone’s News & Events webpage
Historical Context
-
New hires received 123,000 stock options under the 2021 Inducement Plan.
-
CARDAMYST added to Express Scripts commercial national formularies, broadening access.
-
Reported 2025 results with CARDAMYST FDA approval and U.S. launch details.
-
ACC.26 data showed minimal blood pressure impact and low hypotension/syncope rates.
-
Announced timing and access details for Q4 and full-year 2025 results call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference to take place April 13 - 16, 2026.
A webcast of the presentation will be available on April 13th at 3:45 PM EDT. The webcast will be available to watch here and there will be a replay for approximately 90 days on the News & Events section of Milestone's website www.milestonepharma.com.
If you are interested in meeting with the Milestone team during the conference, please contact your Needham representative.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone’s lead product is CARDAMYST™ (etripamil) nasal spray, a novel calcium channel blocker, which is FDA approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in development for the control of symptomatic episodic attacks associated with AFib-RVR.
Contact:
Investor Relations
Kevin Gardner, kgardner@lifesciadvisors.com
Media Relations
Rebecca Novak, rnovak@milestonepharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.